These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35596168)

  • 1. Factors influencing changes in medication-taking and driving behavior after warnings about prescription medications that prohibit driving: an online survey.
    Fukuda Y; Saito M
    BMC Public Health; 2022 May; 22(1):1020. PubMed ID: 35596168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital outpatients' responses to taking medications with driving warnings.
    Smyth T; Sheehan M; Siskind V
    Traffic Inj Prev; 2013; 14(1):18-25. PubMed ID: 23259515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a Japanese drug alert pictogram on medication-taking/driving behavior.
    Fukuda Y; Ando S; Saito M
    Traffic Inj Prev; 2020; 21(1):18-23. PubMed ID: 31770002
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk awareness, medication adherence, and driving behavior as determined by the provision of drug information to patients.
    Fukuda Y; Ando S; Saito M
    Patient Educ Couns; 2020 Aug; 103(8):1574-1580. PubMed ID: 32173213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receipt of Warnings Regarding Potentially Impairing Prescription Medications and Associated Risk Perceptions in a National Sample of U.S. Drivers.
    Pollini RA; Waehrer G; Kelley-Baker T
    J Stud Alcohol Drugs; 2017 Nov; 78(6):805-813. PubMed ID: 29087813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medications and risk of motor vehicle collision responsibility in British Columbia, Canada: a population-based case-control study.
    Brubacher JR; Chan H; Erdelyi S; Zed PJ; Staples JA; Etminan M
    Lancet Public Health; 2021 Jun; 6(6):e374-e385. PubMed ID: 33887232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Number of medications and road traffic crashes in senior Swedish drivers: a population-based matched case-control study.
    Monárrez-Espino J; Laflamme L; Elling B; Möller J
    Inj Prev; 2014 Apr; 20(2):81-7. PubMed ID: 23873499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic and Demographic Characteristics of US Adults Who Purchase Prescription Drugs From Other Countries.
    Hong YR; Hincapie-Castillo JM; Xie Z; Segal R; Mainous AG
    JAMA Netw Open; 2020 Jun; 3(6):e208968. PubMed ID: 32579194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
    Baumann M; Trincard M
    Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an integrated collision warning system on teenage driver behavior.
    Jermakian JS; Bao S; Buonarosa ML; Sayer JR; Farmer CM
    J Safety Res; 2017 Jun; 61():65-75. PubMed ID: 28454872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consumer perceptions of medication warnings about driving: a comparison of French and Australian labels.
    Smyth T; Sheehan M; Siskind V; Mercier-Guyon C; Mallaret M
    Traffic Inj Prev; 2013; 14(6):557-64. PubMed ID: 23859486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with medication amounts considered excessive among university students: a questionnaire survey of pharmacy students and those in non-medical schools.
    Saito M; Ando-Tanabe N; Arita E
    BMC Health Serv Res; 2017 Jul; 17(1):475. PubMed ID: 28697734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceptions and attitudes toward risk and personal responsibility in the context of medical fitness to drive.
    Ryan M; Walshe J; Booth R; O'Neill DJ
    Traffic Inj Prev; 2020; 21(6):365-370. PubMed ID: 32421397
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigating the effects of driving environment and driver characteristics on drivers' compliance with speed limits.
    Yadav AK; Velaga NR
    Traffic Inj Prev; 2021; 22(3):201-206. PubMed ID: 33688753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to multiple, prescribed medications in diabetic kidney disease: A qualitative study of consumers' and health professionals' perspectives.
    Williams AF; Manias E; Walker R
    Int J Nurs Stud; 2008 Dec; 45(12):1742-56. PubMed ID: 18701103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patients Taking Antihistamines and Their Effects on Driving].
    Kizu J
    Yakugaku Zasshi; 2017; 137(3):315-321. PubMed ID: 28250327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of health literacy on beliefs about medication in a Dutch medication-using population.
    Visscher BBB; Steunenberg BB; Zwikker HH; Heerdink ERR; Rademakers JJ
    Eur J Clin Pharmacol; 2021 Aug; 77(8):1219-1224. PubMed ID: 33594447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Driving under the influence, public policy, and pharmacy practice.
    Sigona N; Williams KG
    J Pharm Pract; 2015 Feb; 28(1):119-23. PubMed ID: 25312259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially driver-impairing (PDI) medication use in medically impaired adults referred for driving evaluation.
    Hetland AJ; Carr DB; Wallendorf MJ; Barco PP
    Ann Pharmacother; 2014 Apr; 48(4):476-82. PubMed ID: 24473491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practicing for and performance on drivers license tests in relation to gender differences in crash involvement among novice drivers.
    Nyberg A; Gregersen NP
    J Safety Res; 2007; 38(1):71-80. PubMed ID: 17300806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.